PO-0740: An image-guided SBRT phase II study with a dose of 42 Gy in 7 fractions for the localized prostate cancer. (April 2015) - Foti, C.; Magli, A.; Malisan, M.R.; Ceschia, T.; Crespi, M.; Prisco, A.; Parisi, G.; Titone, F.; Fongione, S.